Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pernelle Pulh

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cold Spring Harbor Perspectives in Biology|June 10, 2024
Glia at Transition ZonesSarah Kucenas, Pernelle Pulh, Piotr Topilko, et al.
Acta Neuropathologica Communications|July 19, 2025
Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1Pernelle Pulh, Fanny Coulpier, Audrey Onfroy, et al.
Elife|December 14, 2023
Neural tube-associated boundary caps are a major source of mural cells in the skinGaspard Gerschenfeld, Fanny Coulpier, Aurélie Gresset, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 18, 2023
Topical delivery of mitogen-activated protein kinase inhibitor binimetinib prevents the development of cutaneous neurofibromas in neurofibromatosis type 1 mutant miceFanny Coulpier, Pernelle Pulh, Layna Oubrou, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cold Spring Harbor Perspectives in Biology|June 10, 2024
Glia at Transition ZonesSarah Kucenas, Pernelle Pulh, Piotr Topilko, et al.
Acta Neuropathologica Communications|July 19, 2025
Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1Pernelle Pulh, Fanny Coulpier, Audrey Onfroy, et al.
Elife|December 14, 2023
Neural tube-associated boundary caps are a major source of mural cells in the skinGaspard Gerschenfeld, Fanny Coulpier, Aurélie Gresset, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 18, 2023
Topical delivery of mitogen-activated protein kinase inhibitor binimetinib prevents the development of cutaneous neurofibromas in neurofibromatosis type 1 mutant miceFanny Coulpier, Pernelle Pulh, Layna Oubrou, et al.
Pageof 1